Tue, Mar 28, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

AIMA calls for deeper global coordination of OTC derivatives regulation

Tuesday, May 28, 2013
Opalesque Industry Update - The Alternative Investment Management Association (AIMA), the global hedge fund industry association, has produced a paper that highlights the key areas where deeper coordination of over-the-counter (OTC) derivatives regulation is required to achieve the G20 objective of maintaining global markets.

The paper, ‘Addressing overlaps between EMIR and CFTC OTC derivatives regulation’, provides examples of potential regulatory conflicts or unnecessary overlap between the European Markets Infrastructure Regulation (EMIR) and the CFTC’s derivatives rules in a number of key areas including clearing obligations, reporting obligations, segregation rules, collateral rules and margin requirements.

AIMA said in the paper that, if untreated, some of the conflicting rules may prevent counterparties from complying with either regime, leading to market fragmentation along geographical boundaries. AIMA said these effects could be mitigated for cross-border transactions by firms being allowed to follow the rules of the jurisdiction of one, rather than both counterparties to a transaction under a concept known as ‘substituted compliance’ in the US or ‘equivalence’ in the EU.

In the US and Europe, the CFTC, the US Securities and Exchange Commission and the European Commission, respectively, will soon determine the scope of their derivatives regulatory regime with respect to cross-border transactions. These decisions which will address the scope of substituted compliance and equivalence recognition will have a significant impact on the nature of the global derivatives market.

Andrew Baker, AIMA CEO, said: “AIMA strongly supports efforts to promote central clearing of OTC derivatives and to reduce systemic risk, and we appreciate the difficult task that regulators in each jurisdiction face in completing their separate OTC derivatives regulations in a prompt and thorough manner, while also ensuring that those regulations are, as far as possible, consistent with regulations being finalised and implemented by other regulatory authorities.

“However, we are concerned that OTC derivatives transactions could be subject to unnecessarily duplicative – or even conflicting – requirements as a result of extra-territorial application of domestic rules. The good news is that the regulatory authorities have the tools at their disposal to ensure we avoid market fragmentation and they are mindful of some of the potential negative consequences of uncoordinated action. We hope that, by highlighting the key examples of potential problems, our paper contributes to the current intensive international regulatory dialogue.”

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hedge fund liquidations in 2016 surpass 2009 levels, new launches decline[more]

    Benedicte Gravrand, Opalesque Geneva: Even as the hedge fund industry's total assets exceeded the $3tln milestone last year, hedge fund liquidations increased. So much so that 2016 had the highest number of liquidations since 2008, claims the latest HFR Market Microstructure Report, re

  2. Hedge funds find no joy in macro as returns lag Trump rally[more]

    From Gulfnews.com: In 2017, macro hedge funds were expected to shine. So far? Not so much. It's been a far from impressive first two months for funds that trade around macroeconomic events. Discretionary funds rose just 0.3 per cent through February, according to Hedge Fund Research Inc., while the

  3. Strategies - Billionaire investor Marc Lasry shares how he's playing markets right now, Classic models are failing FX hedge funds desperate for return[more]

    Billionaire investor Marc Lasry shares how he's playing markets right now From CNBC.com: Buy on the prospect of deregulation. Sell on the enactment of deregulation. That's the strategy that billionaire investor Marc Lasry is implementing, according to an interview with CNBC in Las Vegas

  4. Opalesque Exclusive: Aberdeen makes the case for the lower mid-market[more]

    Bailey McCann, Opalesque New York: Aberdeen Asset Management has released a new paper focused on lower mid-market private equity. According to the paper, this segment of the private equity market is gaining popularity with private equity investors that are looking for multiple expansion and less

  5. Hedge funds await outcome of French elections, feel pinch on lower oil prices & weak dollar[more]

    Komfie Manalo, Opalesque Asia: Hedge funds felt the pinch of lower oil prices and weak U.S. dollar as the Lyxor Hedge Fund Index was marginally down as of the week ending 14 March, Lyxor Asset Management said in its Weekly Briefing. The Lyxor He